Reuters logo
BRIEF-Vistin Pharma Q3 EBITDA down at NOK 4.3‍​ mln
October 27, 2017 / 5:28 AM / 24 days ago

BRIEF-Vistin Pharma Q3 EBITDA down at NOK 4.3‍​ mln

Oct 27 (Reuters) - VISTIN PHARMA ASA

* REG-VISTIN PHARMA ASA : THIRD QUARTER 2017 RESULTS - STRONG GROWTH, CAPACITY EXPANSION ON TRACK

* REVENUE OF NOK 46.7 MILLION FOR Q3 VERSUS. NOK 38.3 MILLION IN Q3 2016

* Q3 EBITDA NOK 4.3‍​ MILLION VERSUS NOK 5.1 MILLION YEAR AGO

* TO MEET EXPECTED GROWTH IN DEMAND FOR METFORMIN GLOBALLY, CO TO INCREASE CURRENT PRODUCTION CAPACITY

* CO TO INCREASE CURRENT PRODUCTION CAPACITY BY ANOTHER 3,000MT, A DOUBLING FROM THE CURRENT CAPACITY Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below